209 related articles for article (PubMed ID: 10804603)
21. Clinical impact of ex vivo differentiated myeloid precursors after high-dose chemotherapy and peripheral blood progenitor cell rescue.
Zimmerman TM; Lee WJ; Bender JG; Schilling M; Smith SL; Van Epps DE; Williams SF
Bone Marrow Transplant; 2000 Sep; 26(5):505-10. PubMed ID: 11019839
[TBL] [Abstract][Full Text] [Related]
22. Optimization of CD34+ collection for autologous transplantation using the evolution of peripheral blood cell counts after mobilization with chemotherapy and G-CSF.
Delamain MT; Metze K; Marques JF; Reis AR; De Souza CA; Lorand-Metze I
Transfus Apher Sci; 2006 Feb; 34(1):33-40. PubMed ID: 16376618
[TBL] [Abstract][Full Text] [Related]
23. Mobilization strategies for the collection of peripheral blood progenitor cells: Results from a pilot study of delayed addition G-CSF following chemotherapy and review of the literature.
Jacoub JF; Suryadevara U; Pereyra V; Colón D; Fontelonga A; Mackintosh FR; Hall SW; Ascensão JL
Exp Hematol; 2006 Nov; 34(11):1443-50. PubMed ID: 17046563
[TBL] [Abstract][Full Text] [Related]
24. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
[TBL] [Abstract][Full Text] [Related]
25. Large volume leukapheresis in small children: safety profile and variables affecting peripheral blood progenitor cell collection.
Sevilla J; González-Vicent M; Madero L; García-Sánchez F; Angel Diaz M
Bone Marrow Transplant; 2003 Feb; 31(4):263-7. PubMed ID: 12621460
[TBL] [Abstract][Full Text] [Related]
26. Correlation of hematopoietic progenitor cell count determined by the SE-automated hematology analyzer with CD34(+) cell count by flow cytometry in leukapheresis products.
Park KU; Kim SH; Suh C; Kim S; Lee SJ; Park JS; Cho HJ; Kim KW; Lee K; Kim HJ; Park J; Joo Min Y; Kim JG; Kim T; Lee JH; Kim SB; Kim SW; Lee KH; Lee JS; Kim WK; Park CJ; Chi HS
Am J Hematol; 2001 May; 67(1):42-7. PubMed ID: 11279656
[TBL] [Abstract][Full Text] [Related]
27. A single dose of 6 or 12 mg of pegfilgrastim for peripheral blood progenitor cell mobilization results in similar yields of CD34+ progenitors in patients with multiple myeloma.
Bruns I; Steidl U; Kronenwett R; Fenk R; Graef T; Rohr UP; Neumann F; Fischer J; Scheid C; Hübel K; Haas R; Kobbe G
Transfusion; 2006 Feb; 46(2):180-5. PubMed ID: 16441592
[TBL] [Abstract][Full Text] [Related]
28. Preclinical ex vivo expansion of peripheral blood CD34+ selected cells from cancer patients mobilized with combination chemotherapy and granulocyte colony-stimulating factor.
Lorenzon D; Mazzucato M; Abbruzzese L; Cilli M; De Angeli S; Degan M; Mambrini G; Piccardi F; Rupolo M; Michieli M; De Marco L; Gattei V; Astori G
Vox Sang; 2008 May; 94(4):342-50. PubMed ID: 18282263
[TBL] [Abstract][Full Text] [Related]
29. Factors influencing hematopoietic recovery after autologous blood stem cell transplantation in patients with acute myeloblastic leukemia and with non-myeloid malignancies.
Carral A; de la Rubia J; Martín G; Martínez J; Sanz G; Jarque I; Sempere A; Soler MA; Marty ML; Sanz MA
Bone Marrow Transplant; 2002 May; 29(10):825-32. PubMed ID: 12058232
[TBL] [Abstract][Full Text] [Related]
30. Kinetics of standardized large volume leukapheresis (LVL) in patients do not show a recruitment phenomenon of peripheral blood progenitor cells (PBPC).
Cassens U; Momkvist PH; Zuehlsdorf M; Mohr M; Kienast J; Berdel WE; Sibrowski W
Bone Marrow Transplant; 2001 Jul; 28(1):13-20. PubMed ID: 11498739
[TBL] [Abstract][Full Text] [Related]
31. Comparative assays of megakaryocyte progenitors in CD34+ peripheral blood progenitor cell fractions.
Petsche D; Hami L; Purdy M; Myers S; Hogan C; Messner H; Briddell R; Heimfeld S; Berenson R; Shpall E
Prog Clin Biol Res; 1994; 389():415-20. PubMed ID: 7535450
[No Abstract] [Full Text] [Related]
32. Role of the CD34+ 38- cells in posttransplant hematopoietic recovery.
Hénon P; Sovalat H; Bourderont D; Ojeda-Uribe M; Arkam Y; Wunder E; Raidot JP; Husseini F; Audhuy B
Stem Cells; 1998; 16 Suppl 1():113-22. PubMed ID: 11012153
[TBL] [Abstract][Full Text] [Related]
33. In leukapheresis products from non-Hodgkin's lymphoma patients, the immature hematopoietic progenitors show higher CD90 and CD34 antigenic expression.
Villaron EM; Almeida J; Lopez-Holgado N; Sanchez-Guijo FM; Alberca M; Blanco B; Sanchez-Abarca LI; Lopez O; Perez-Simon JA; San Miguel JF; del Cañizo MC
Transfus Apher Sci; 2007 Oct; 37(2):145-56. PubMed ID: 17983836
[TBL] [Abstract][Full Text] [Related]
34. Frequent viral infections and delayed CD4+ cell recovery following CD34+ cell-selected autologous peripheral blood stem cell transplantation.
Takeshima M; Takamatsu H; Iida M; Mochizuki Y; Okumura H; Yoshida T
Int J Hematol; 1999 Oct; 70(3):193-9. PubMed ID: 10561914
[TBL] [Abstract][Full Text] [Related]
35. Transfusion-associated iron overload as a predictive factor for poor stem cell mobilization in patients with haematological malignancies.
Park IH; Kim Y; Kim JS; Cheong JW; Song JW; Min YH
Transfus Med; 2008 Apr; 18(2):97-103. PubMed ID: 18399843
[TBL] [Abstract][Full Text] [Related]
36. Comparison of processing four and five times the patients' blood volume during peripheral blood stem cell collection and analysis of CD34+38--and CD34+49d+ subsets during apheresis.
Bojko P; Scharifi M; Stössel K; Seeber S
J Cancer Res Clin Oncol; 2002 Jan; 128(1):19-28. PubMed ID: 11862468
[TBL] [Abstract][Full Text] [Related]
37. Progenitor cell recruitment during individualized high-flow, very-large-volume apheresis for autologous transplantation improves collection efficiency.
Fontana S; Groebli R; Leibundgut K; Pabst T; Zwicky C; Taleghani BM
Transfusion; 2006 Aug; 46(8):1408-16. PubMed ID: 16934079
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of an algorithm based on peripheral blood hematopoietic progenitor cell and CD34+ cell concentrations to optimize peripheral blood progenitor cell collection by apheresis.
Lefrère F; Zohar S; Beaudier S; Audat F; Ribeil JA; Ghez D; Varet B; Cavazzana-Calvo M; Dal Cortivo L; Letestu R; McIntyre E; Brouzes C
Transfusion; 2007 Oct; 47(10):1851-7. PubMed ID: 17880611
[TBL] [Abstract][Full Text] [Related]
39. Large-volume leukapheresis yields more viable CD34+ cells and colony-forming units than normal-volume leukapheresis, especially in patients who mobilize low numbers of CD34+ cells.
Abrahamsen JF; Stamnesfet S; Liseth K; Hervig T; Bruserud O
Transfusion; 2005 Feb; 45(2):248-53. PubMed ID: 15660835
[TBL] [Abstract][Full Text] [Related]
40. CD34+ selection of autologous peripheral blood stem cells for transplantation following sequential cycles of high-dose therapy and mobilization in multiple myeloma.
Dyson PG; Horvath N; Joshua D; Barrow L; Van Holst NG; Brown R; Gibson J; To LB
Bone Marrow Transplant; 2000 Jun; 25(11):1175-84. PubMed ID: 10849530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
